Articles

An MDVIP study reports that 61% of people feel hassled by the current structure. 


Survey Reveals Americans’ Frustrations With the Healthcare System

Videos

In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement, Policy Insights, Cencora, provides a look at his recent webinar focused on the implications of the Inflation Reduction Act. 

Cencora VP of Reimbursement & Policy Insights Discusses Implications of the Inflation Reduction Act

An investigation evaluates whether SNAP benefits can also influence hypertension patients’ lack of medication adherence. 

Does Food Insecurity Impact Adherence to Antihypertensive Medications?

Compared with piperacillin/tazobactam, Exblifep (cefepime/enmetazobactam) showed noninferiority and superiority in a clinical cure and microbiological eradication of complicated urinary tract infections.

FDA Approves Antibiotic Combination for Complicated Urinary Tract Infections 

Current production of Qdenga will increase to 50 million doses a year. 

Takeda, Biological E. Team Up to Provide Dengue Vaccine Access to Endemic Countries

Epkinly (epcoritamab-bysp), a subcutaneously administered, T-cell engaging, bispecific antibody, was previously granted Breakthrough Therapy Designation for the treatment of patients with relapsed or refractory follicular lymphoma following two or more prior lines of therapy.

FDA Grants Priority Review to Epkinly for Relapsed/Refractory Follicular Lymphoma 

A cohort study explores the association of Medicare Advantage enrollment with post-acute care use, along with patient outcomes among retired state employees.

The Perks of Medicare Advantage Versus Traditional Medicare

The company’s cloud technology services aim to assist healthcare and pharma with AI integration. 

Healthcare Triangle Introduces New SaaS Solution

Xolair was approved last week to reduce allergic reactions from exposure to one or more food allergens in individuals over 1 year of age with IgE-mediated food allergy.

Xolair Demonstrates Efficacy Reducing Multi-Food Allergic Reactions

Bayer's BAY 2927088 is under evaluation to treat unresectable or metastatic non-small cell lung cancer with tumors harboring activating HER2 mutations.

News